Refine
Has Fulltext
- yes (25)
Is part of the Bibliography
- yes (25)
Year of publication
Document Type
- Journal article (25)
Language
- English (25) (remove)
Keywords
- T cells (4)
- dendritic cells (4)
- regulatory T cells (4)
- GM-CSF (2)
- Medizin (2)
- Parkinson’s disease (2)
- immune evasion (2)
- macrophages (2)
- monocytes (2)
- Allotransplantation (1)
- Alpha therapy (1)
- Aspergillus fumigatus (1)
- Autoimmune diseases (1)
- BCG (1)
- Bone marrow transplantantation (1)
- Brugia Malayi (1)
- CD39 (1)
- CD73 (1)
- DAPI staining (1)
- Dendritic cells (1)
- Dendritische Zelle (1)
- Expression (1)
- Factor receptor (1)
- Flt3L (1)
- Graft-versus-leukemia (1)
- IL-2 (1)
- IL-3 (1)
- IL‐10 (1)
- Immunology (1)
- Immunosuppression (1)
- Infectious disease (1)
- LIF (1)
- Langerhans cells (1)
- Mesocestoides corti (1)
- Monocytes and macrophages (1)
- Multiple myeloma (1)
- Mycobacterium tuberculosis (1)
- Regulatory T cells (1)
- Regulatory-cells (1)
- RelB (1)
- Rheumatoid arthritis (1)
- Suppression (1)
- T Cells (1)
- T cell suppression (1)
- T helper cell responses (1)
- TGF-BETA (1)
- TLR2 (1)
- TLR4 (1)
- TNF-alpha (1)
- Tr1 (1)
- Tumor-necrosis-factor (1)
- VLA-1 (1)
- adenosine (1)
- alveoar echinococcosis (1)
- anergy (1)
- antigen-B (1)
- aorta (1)
- bacteria (1)
- bone marrow (1)
- cDC2 subset (1)
- caveolin-1 (Cav-1) (1)
- cell differentiation (1)
- cell staining (1)
- cholera (1)
- conversion (1)
- cytokines (1)
- diet (1)
- epicutaneous (1)
- excretory-secretory (1)
- flow cytometry (1)
- fungal infection (1)
- gene expression (1)
- granulosus (1)
- helminths (1)
- homing (1)
- host-pathogen interactions (1)
- humans (1)
- hydatid disease (1)
- immune control (1)
- immune escape (1)
- immune response (1)
- immunoprecipitation (1)
- in vitro culture (1)
- in vivo (1)
- innate immune response (1)
- larvae (1)
- lymph nodes (1)
- metacestode vesicles (1)
- migration (1)
- murine model (1)
- mycobacteria (1)
- myeloid-derived suppressor cell (MDSC) (1)
- myeloid-derived suppressor cells (MDSC) (1)
- myeloid-derived suppressor cells (MDSCs) (1)
- neurodegeneration (1)
- neuroinflammation (1)
- neuroprotection (1)
- ovarian cancer (1)
- parasitic diseases (1)
- primary cells (1)
- proteomic analysis (1)
- protocol (1)
- small interfering RNAs (1)
- spleen (1)
- steady state (1)
- steady-state dendritic cells (1)
- tolerance (1)
- tolerogenic dendritic cells (1)
- toxins (1)
- transcriptional profiling (1)
- transcutaneous (1)
- transient regulatory T-cell targeting (1)
- tumor associated macrophages (1)
- vesicles (1)
- α-synuclein-specific T cells (1)
Institute
- Institut für Virologie und Immunbiologie (25)
- Medizinische Klinik und Poliklinik II (5)
- Institut für Hygiene und Mikrobiologie (3)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (2)
- Neurologische Klinik und Poliklinik (2)
- Pathologisches Institut (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Frauenklinik und Poliklinik (1)
EU-Project number / Contract (GA) number
- 825575 (1)
Human regulatory macrophages (Mreg) have shown early clinical promise as a cell-based adjunct immunosuppressive therapy in solid organ transplantation. It is hypothesised that recipient CD4(+) T cell responses are actively regulated through direct allorecognition of donor-derived Mregs. Here we show that human Mregs convert allogeneic CD4(+) T cells to IL-10-producing, TIGIT(+) FoxP3(+)-induced regulatory T cells that non-specifically suppress bystander T cells and inhibit dendritic cell maturation. Differentiation of Mreg-induced Tregs relies on multiple non-redundant mechanisms that are not exclusive to interaction of Mregs and T cells, including signals mediated by indoleamine 2,3-dioxygenase, TGF-beta, retinoic acid, Notch and progestagen-associated endometrial protein. Preoperative administration of donor-derived Mregs to living-donor kidney transplant recipients results in an acute increase in circulating TIGIT(+) Tregs. These results suggest a feed-forward mechanism by which Mreg treatment promotes allograft acceptance through rapid induction of direct-pathway Tregs.
Immature or semi-mature dendritic cells (DCs) represent tolerogenic maturation stages that can convert naive T cells into Foxp3\(^{+}\) induced regulatory T cells (iTreg). Here we found that murine bone marrow-derived DCs (BM-DCs) treated with cholera toxin (CT) matured by up-regulating MHC-II and costimulatory molecules using either high or low doses of CT (CT\(^{hi}\), CT\(^{lo}\)) or with cAMP, a known mediator CT signals. However, all three conditions also induced mRNA of both isoforms of the tolerogenic molecule cytotoxic T lymphocyte antigen 2 (CTLA-2α and CTLA-2β). Only DCs matured under CT\(^{hi}\) conditions secreted IL-1β, IL-6 and IL-23 leading to the instruction of Th17 cell polarization. In contrast, CT\(^{lo}\)- or cAMP-DCs resembled semi-mature DCs and enhanced TGF-β-dependent Foxp3\(^{+}\) iTreg conversion. iTreg conversion could be reduced using siRNA blocking of CTLA-2 and reversely, addition of recombinant CTLA-2α increased iTreg conversion in vitro. Injection of CT\(^{lo}\)- or cAMP-DCs exerted MOG peptide-specific protective effects in experimental autoimmune encephalomyelitis (EAE) by inducing Foxp3\(^{+}\) Tregs and reducing Th17 responses. Together, we identified CTLA-2 production by DCs as a novel tolerogenic mediator of TGF-β-mediated iTreg induction in vitro and in vivo. The CT-induced and cAMP-mediated up-regulation of CTLA-2 also may point to a novel immune evasion mechanism of Vibrio cholerae.
T cell anergy is a common mechanism of T cell tolerance. However, although anergic T cells are retained for longer time periods in their hosts, they remain functionally passive. Here, we describe the induction of anergic CD4\(^+\) T cells in vivo by intravenous application of high doses of antigen and their subsequent conversion into suppressive Foxp3\(^-\) IL-10\(^+\) Tr1 cells but not Foxp3\(^+\) Tregs. We describe the kinetics of up-regulation of several memory-, anergy- and suppression-related markers such as CD44, CD73, FR4, CD25, CD28, PD-1, Egr-2, Foxp3 and CTLA-4 in this process. The conversion into suppressive Tr1 cells correlates with the transient intracellular CTLA-4 expression and required the restimulation of anergic cells in a short-term time window. Restimulation after longer time periods, when CTLA-4 is down-regulated again retains the anergic state but does not lead to the induction of suppressor function. Our data require further functional investigations but at this stage may suggest a role for anergic T cells as a circulating pool of passive cells that may be re-activated into Tr1 cells upon short-term restimulation with high and systemic doses of antigen. It is tentative to speculate that such a scenario may represent cases of allergen responses in non-allergic individuals.
Dendritic cells (DCs) are key directors of tolerogenic and immunogenic immune responses. During the steady state, DCs maintain T cell tolerance to self-antigens by multiple mechanisms including inducing anergy, deletion, and Treg activity. All of these mechanisms help to prevent autoimmune diseases or other hyperreactivities. Different DC subsets contribute to pathogen recognition by expression of different subsets of pattern recognition receptors, including Toll-like receptors or C-type lectins. In addition to the triggering of immune responses in infected hosts, most pathogens have evolved mechanisms for evasion of targeted responses. One such strategy is characterized by adopting the host's T cell tolerance mechanisms. Understanding these tolerogenic mechanisms is of utmost importance for therapeutic approaches to treat immune pathologies, tumors and infections. Transcriptional profiling has developed into a potent tool for DC subset identification. Here, we review and compile pathogen-induced tolerogenic transcriptional signatures from mRNA profiling data of currently available bacterial- or helminth-induced transcriptional signatures. We compare them with signatures of tolerogenic steady-state DC subtypes to identify common and divergent strategies of pathogen induced immune evasion. Candidate molecules are discussed in detail. Our analysis provides further insights into tolerogenic DC signatures and their exploitation by different pathogens.
Accumulating evidences have assigned a central role to parasite-derived proteins in immunomodulation. Here, we report on the proteomic identification and characterization of immunomodulatory excretory-secretory (ES) products from the metacestode larva (tetrathyridium) of the tapeworm Mesocestoides corti (syn. M. vogae). We demonstrate that ES products but not larval homogenates inhibit the stimuli-driven release of the pro-inflammatory, Th1-inducing cytokine IL-12p70 by murine bone marrow-derived dendritic cells (BMDCs). Within the ES fraction, we biochemically narrowed down the immunosuppressive activity to glycoproteins since active components were lipid-free, but sensitive to heat- and carbohydrate-treatment. Finally, using bioassay-guided chromatographic analyses assisted by comparative proteomics of active and inactive fractions of the ES products, we defined a comprehensive list of candidate proteins released by M. corti tetrathyridia as potential suppressors of DC functions. Our study provides a comprehensive library of somatic and ES products and highlight some candidate parasite factors that might drive the subversion of DC functions to facilitate the persistence of M. corti tetrathyridia in their hosts.